Literature DB >> 856022

Levels of carbenicillin, ticarcillin, cephalothin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluid.

J S Tan, S J Salstrom.   

Abstract

The ability of eight antibiotics (carbenicillin, ticarcillin, cefamandole, cephalothin, cefazolin, gentamicin, tobramycin, and amikacin) to enter human interstitial fluid was evaluated by the skin window technique. All of the antibiotics tested, except cefazolin, which has the highest percentage of protein binding, diffused into the interstitial fluid quite well. This study confirms our previous observation on the effect of high-percentage protein binding on diffusion of a drug into the minimally inflamed extravascular space.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856022      PMCID: PMC352053          DOI: 10.1128/AAC.11.4.698

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

Review 1.  Drug therapy: The newer cephalosporins.

Authors:  R C Moellering; M N Swartz
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

2.  Clinical pharmacology of cefamandole as compared with cephalothin.

Authors:  I W Fong; E D Ralph; E R Engelking; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

3.  Levels of amoxicillin and ampicillin in human serum and interstitial fluid.

Authors:  J A Tan; T Bannister; J P Phair
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

4.  A method for measurement of antibiotics in human interstitial fluid.

Authors:  J S Tan; A Trott; J P Phair; C Watanakunakorn
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

5.  Serum protein binding of the aminoglycoside antibiotics.

Authors:  R C Gordon; C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

6.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

7.  Comparative pharmacokinetics of amikacin and kanamycin.

Authors:  J T Clarke; R D Libke; C Regamey; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1974-06       Impact factor: 6.875

8.  Ticarcillin vs carbenicillin: clinical pharmacokinetics.

Authors:  R D Libke; J T Clarke; E D Ralph; R P Luthy; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

9.  Antibiotic levels in pericardial fluid.

Authors:  J S Tan; J C Holmes; N O Fowler; G T Manitsas; J P Phair
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

  9 in total
  18 in total

1.  Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics.

Authors:  S Tawara; S Matsumoto; T Kamimura; S Goto
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 2.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

3.  Effect of protein binding on drug penetration into blister fluid.

Authors:  W C Shyu; R Quintiliani; C H Nightingale; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

4.  Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid.

Authors:  J N Bruun; N Ostby; J E Bredesen; P Kierulf; P K Lunde
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 5.  Pharmacokinetics and pharmacodynamics of antibacterial agents.

Authors:  Matthew E Levison; Julie H Levison
Journal:  Infect Dis Clin North Am       Date:  2009-12       Impact factor: 5.982

Review 6.  Why monitor serum levels of gentamicin?

Authors:  M Barza; M Lauermann
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

7.  Role of serum protein binding and multiple antibiotic doses in the extravascular distribution of ceftizoxime and cefotaxime.

Authors:  D N Gerding; L L Van Etta; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

8.  The metabolic disposition of flucloxacillin in patients with impaired kidney function.

Authors:  H H Thijssen; J Wolters
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.

Authors:  D N Gerding; L R Peterson; D C Legler; W H Hall; E A Schierl
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

10.  Ticarcillin serum and tissue concentrations in gynecology and obstetrics.

Authors:  D von Kobyletzki; A Dalhoff; H Lindemeyer; C A Primavesi
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.